GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Adagio Medical Holdings Inc (NAS:ADGM) » Definitions » Insider Ownership

ADGM (Adagio Medical Holdings) Insider Ownership : 0.30 % (As of Dec. 12, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Adagio Medical Holdings Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Adagio Medical Holdings's insider ownership is 0.30%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Adagio Medical Holdings's Institutional Ownership is 82.69%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Adagio Medical Holdings's Float Percentage Of Total Shares Outstanding is 0.00%.


Adagio Medical Holdings Insider Ownership Historical Data

The historical data trend for Adagio Medical Holdings's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adagio Medical Holdings Insider Ownership Chart

Adagio Medical Holdings Historical Data

The historical data trend for Adagio Medical Holdings can be seen below:

2024-08-31 2024-09-30 2024-10-31 2024-11-30
Insider Ownership 0.33 0.33 0.33 0.30

Adagio Medical Holdings Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.


Adagio Medical Holdings Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
26051 Merit Circle, Suite 102, Laguna Hills, CA, USA, 92653
Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for treatment of cardiac arrhythmias. The company focuses on developing innovative cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.